- Milecular diagnosis of EGFR gene mutations for biological therapy with tyrosine kinase inhibitors in patients with non-small-cell ung cancer.2010 | First Faculty of Medicine
- Afatinib as first-line therapy of advanced lung cancer2014 | First Faculty of Medicine
- Chronic myeloid leukemia and pregnancy2017 | First Faculty of Medicine
- Current treatment options for renal cell carcinoma and outlook2020 | Publication without faculty affiliation
- Inflammatory myofibroblastic tumor of the uterus - case report2019 | Faculty of Medicine in Pilsen
- Sorafenib - a new molecule for the treatment of differentiated thyroid cancer2015 | Publication without faculty affiliation
- Nonsmall cell lung cancer with RET gene fusion2021 | Publication without faculty affiliation
- Ceritinib - a new hope for patients with ALK-positive translocation of non-small-cell lung cancers +12015 | Faculty of Medicine in Pilsen
- Current treatment options for thyroid cancer2015 | Second Faculty of Medicine
- Survival of patients as a function of MSKCC scores for sunitinib treatment in the 1st mRCC treatment line2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Commentary to the study +12009 | Faculty of Medicine in Hradec Králové
- Pacientka s hepatocelulárním karcinomem a metastázami do plic: "Kolik lenvatinibu stačí?"2022 | Third Faculty of Medicine
- Gastrointestinal stromal tumours (GIST)2005 | First Faculty of Medicine
- Komentář ke studii (Nintedanib v léčbě idiopatické plicní fibrózy - analýza výsledků studií II. a III. fáze)2016 | First Faculty of Medicine
- Current position of afatinib in the therapy of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- KRAS (G12S) mutation in a patient with NSCLC treated with erlotinib – a case report2013 | Faculty of Medicine in Pilsen
- Nintedanib in the treatment of interstitial lung disease - the view of a rheumatologist. Nintedanib in the treatment of interstitial lung disease - the view of a rheumatologist2020 | First Faculty of Medicine
- Alectinib2017 | Third Faculty of Medicine
- Molecular pathology of pulmonary carcinomas2014 | Third Faculty of Medicine
- News in the treatment of thyroid cancer - view of an endocrinologist2020 | Second Faculty of Medicine
- Efficacy of Janus kinase inhibitors on skin syndrome in patients with psoritic arthritis2022 | First Faculty of Medicine
- Integration of surgery and molecular targeted therapy in advanced renal cell carcinoma2011 | Second Faculty of Medicine